| Compound Information | |
|---|---|
| ID | 127 |
| TrivialName | Ginsenoside Rg1 |
| Type | PPT |
| MF | C₄₂H₇₂O₁₄ |
| MolecularWeight | 801.024 |
| IUPACName | (2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol |
| m/z | 845.4896 |
| Retention Time | 10.21 |
| CCS | 296.6 |
| Adducts | [M−H+HCOOH]− |
| Isomeric SMILES | CC1(C)[C@@H](O[H])CC[C@@]2(C)C1[C@@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)C[C@]4(C)C2C[C@@H](O)C5[C@@]4(C)CCC5[C@@](C)(O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)CC/C=C(C)/C |
| Canonical SMILES | CC(C)=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C1CCC2(C)C1C(O)CC1C3(C)CCC(O)C(C)(C)C3C(OC3OC(CO)C(O)C(O)C3O)CC12C |
| Source | PG |
| Functions | neuroprotective agent, pro-angiogenic agent, anti-viral, Anti-tumor(GJIC modulators), Anti-cancer, hemostatic, Central nervous system excitement, memory and learning improvement, anti-stress, anti-fatigue, platelet aggregation inhibition, vasodilatation |
| Toxicity Organism | mouse |
| Toxicity Type | LD50 |
| Toxicity Route | intraperitoneal |
| Toxicity Dose | 405 mg/kg |
| Year | 1971 |
| References | |
| Structure |
|